Data Snapshot: Aug 04, 2026
<$50K

Jul-2026

Sales

Decline

Trend

6-Month

8

Product Count

SKUs

$18.05

Avg Price

-54.9%

YoY Sales Change

9%

YoY Price Change

Ovis Pharmaceuticals is a trusted cannabis wellness brand based in Alberta, known particularly for its innovative range of medical cannabis products, including softgels, tablets, and topicals rich in THC, CBD, CBG, and CBN. The new yet already popular brand provides a holistic health approach, aiding its users' health journey, available for online ordering across several Canadian outlets. While it is still carving out its brand identity in the cannabis market, Ovis already has a solid following and partnerships in the industry, promising a future of growth and reliability.
Ovis Sales

Market Insights Snapshot

Ovis Historical Sales by Category

In July 2026, Ovis concentrated 100.0% of sales in Capsules, with year-over-year sales down 54.9% and month-over-month down 22.9%. Average price rose 9.0% YoY to $18.05, while share breadth across categories contracted to a single line, implying price mix did not offset volume losses. With no rank reported for Capsules in Alberta, the category-only footprint and double-digit MoM decline signal a contraction phase rather than seasonal volatility.

The shift to a 100.0% Capsules mix alongside a 54.9% YoY decline and a 22.9% MoM slide suggests Ovis is overexposed to a shrinking niche where demand elasticity may be biting despite a 9.0% price increase. The absence of a rank in Alberta and a 71.2% 24-month sales decline indicate positioning drift toward a long-tail presence, where maintaining a single-category focus concentrates risk and reduces optionality for recovery.

Jul-2026 Rank
Capsules
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
100.0%
$18.05
-54.9%
-22.9%
Ovis

Competitive Landscape

Ovis sits at #11 in AB Capsules for July 2026, down 1 position year over year from #10, and flat versus three months ago at #11, indicating a stall below its peak of #7 from April 2025; meanwhile, Tweed held #1 year over year at #1 despite a -3.34% sales change, and Glacial Gold stayed at #2 with a -23.03% sales change, while Emprise Canada climbed from #4 to #3 and Stigma Grow fell from #3 to #5 alongside a -74.37% sales change; this pattern implies Ovis’s rank trajectory has plateaued in the lower tier, with competitor churn above it creating openings that require conversion to regain a top-10 position.

Ovis market ranking for AB Capsules

Ovis

Notable Products

THC Softgel 30-Pack (300mg) posted the largest month-over-month gain at 111.6%, yet it only reached rank 5 while THC Softgel 15-Pack (150mg) fell 34.5% and still held rank 1. CBD Softgels 30-Pack (1500mg CBD) climbed 90.5% but stayed at rank 5 alongside the THC Softgel 30-Pack (300mg), and Blue THC Softgel 50-Pack (125mg) slid 13.0% at rank 3. With all top ten positions occupied by Capsules and two rank-5 SKUs surging on volume despite lower ladder positions, the mix points to price-pack experimentation expanding unit throughput while leadership consolidates around fewer, higher-velocity capsule formats.

Product
Category
Mar-2026
Apr-2026
May-2026
Jun-2026
Jul-2026
MoM %
THC Softgel 15-Pack (150mg)
Capsules
1
1
1
1
1
-34.5%
CBG/CBD/THC 1:1:1 Softgels 15-Pack (75mg CBG, 75mg CBD, 75mg THC)
Capsules
3
2
2
2
2
-46.2%
Blue THC Softgel 50-Pack (125mg)
Capsules
2
3
3
3
3
-13.0%
CBD/THC 1:1 Capsules 15-Pack (150mg CBD, 150mg THC)
Capsules
4
6
>10
4
4
+3.6%
CBD Softgels 30-Pack (1500mg CBD)
Capsules
5
4
4
5
5
+90.5%
THC Softgel 30-Pack (300mg)
Capsules
7
5
4
5
5
+111.6%
CBN Goftgels 10-Pack (200mg CBN)
Capsules
6
>10
4
>10
6
CBD:THC 1:1 Balanced Full Spectrum Softgels 30-Pack (150mg CBD, 150mg THC)
Capsules
>10
7
5
5
7
+4.0%
CBD:THC 50:5 Softgels 15-Pack (750mg CBD, 75mg THC)
Capsules
>10
>10
>10
5
>10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market